ARCHIVES

AACR Supports Bypass Budget; Public Consortium Sequences Mouse Genome

This article is from The Cancer Letter archive.

Vol. 28 No. 19 | May 10, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies

July 18, 1980

No Benefit To Shark Cartilage As Treatment, Large Trial Finds

July 27, 2007

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992